The importance of comorbidity in analysing patient costs in Swedish primary care

Published: February 16, 2006
Category: Bibliography > Papers
Authors: Borgquist LA, Carlsson L, Engstrom SG, Nilsson GH, Ostgren CJ
Countries: Sweden
Language: null
Types: Care Management
Settings: Hospital

BMC Public Health 6:36.

Ryd Primary Health Care Centre, Linköping, Sweden

BACKGROUND: The objective was to explore the usefulness of the morbidity risk adjustment system Adjusted Clinical Groups (ACG), in comparison with age and gender, in explaining and estimating patient costs on an individual level in Swedish primary health care. Data were retrieved from two primary health care centres in southeastern Sweden.

METHODS: A cross-sectional observational study. Data from electronic patient registers from the two centres were retrieved for 2001 and 2002, and patients were grouped into ACGs, expressing the individual combination of diagnoses and thus the comorbidity. Costs per patient were calculated for both years in both centres. Cost data from one centre were used to create ACG weights. These weights were then applied to patients at the other centre. Correlations between individual patient costs, age, gender and ACG weights were studied. Multiple linear regression analyses were performed in order to explain and estimate patient costs.

RESULTS: The variation in individual patient costs was substantial within age groups as well as within ACG weight groups. About 37.7% of the individual patient costs could be explained by ACG weights, and age and gender added about 0.8%. The individual patient costs in 2001 estimated 22.0% of patient costs in 2002, whereas ACG weights estimated 14.3%.

CONCLUSION: ACGs was an important factor in explaining and estimating individual patient costs in primary health care. Costs were explained to only a minor extent by age and gender. However, the usefulness of the ACG system appears to be sensitive to the accuracy of classification and coding of diagnoses by physicians.

PMID: 16483369
PMCID: PMC1459136

Cost Burden Evaluation,Sweden,Co-morbidity,Diagnostic Certainty,Population Markers,Acute Disease/economics,Acute Disease/epidemiology,Age Factors,Adult,Ambulatory Care/economics,Chronic Disease/economics,Chronic Disease/epidemiology,Cost Allocation/methods,Cross-Sectional Studies,Gender,Middle Aged,Primary Health Care/utilization,Risk Adjustment,Sex Factors,Sweden/epidemiology

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top